Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluval AB Immunogenicity and Tolerability Study
NCT01404182Phase 4Completed
- Sponsor
- Fluart Innovative Vaccines
- Start
- Jul 2011
- Primary completion
- Aug 2011
- Modality
- Prophylactic Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Fluval AB vaccine in influenza, sponsored by Fluart Innovative Vaccines. Started Jul 2011; status: completed.
02
Drugs
Fluval AB vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01404182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404182.